|Bid||59.478 x 60000|
|Ask||59.605 x 60000|
|Day's Range||59.183 - 59.672|
|52 Week Range||50.183 - 66.109|
|PE Ratio (TTM)||15.34|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
AbbVie (ABBV) announces Mavyret's sanction in Canada for treatment of HCV across all major genotypes. This gain serves a big boost to the company's product portfolio.
Evercore ISI analyst Josh Schimmer is bullish on biotech.
Shares of Gilead Sciences, General Motors, and American Outdoor Brands can all be bought for a song, and the companies look likely to deliver long-term growth.